TPD52 and Familial prostate cancer: Our present study revealed that PrLZ/PC-1 didn't increase IR induced senescence in prostate cancer cells (Supplementary Figure S3), suggesting PrLZ/PC-1 might did not regulate other mTOR signal downstream targets which were correlated with senescence regulation.